Efficacy and survival analysis of neoadjuvant chemotherapy combined with immunotherapy in locally advanced resectable Siewert type II adenocarcinoma of the esophagogastric junction.

Front Oncol · 2025 · PMC12479550 · PMID 41035671

Europe PMC DOI

hedged sentence

0.0880

closest p · 1.8× alpha

0.0880

boldest claim

The sentences

a numerical trendp=0.088so close (0.05 < p ≤ 0.1)

did not reach statistical significanceno p-value reported

In contrast, although the pCR group showed a numerical trend toward improved RFS (p=0.088), this difference did not reach statistical significance.

also in 1,012 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.